MARKET

SPTX

SPTX

SEAPORT THERAPEUTICS INC
NASDAQ
20.54
-0.56
-2.65%
Closed 16:10 07/27 EDT
OPEN
21.81
PREV CLOSE
21.10
HIGH
22.17
LOW
20.35
VOLUME
117.65K
TURNOVER
--
52 WEEK HIGH
23.00
52 WEEK LOW
14.85
MARKET CAP
1.10B
P/E (TTM)
-1.9861
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at SPTX last week (0720-0724)?
Weekly Report · 22h ago
Weekly Report: what happened at SPTX last week (0713-0717)?
Weekly Report · 07/20 10:35
Seaport Therapeutics Initiated at Buy by HC Wainwright & Co.
Dow Jones · 07/15 10:51
Seaport Therapeutics Price Target Announced at $50.00/Share by HC Wainwright & Co.
Dow Jones · 07/15 10:51
HC Wainwright & Co. Initiates Coverage On Seaport Therapeutics with Buy Rating, Announces Price Target of $50
Benzinga · 07/15 10:42
Seaport Therapeutics initiated with a Buy at H.C. Wainwright
TipRanks · 07/15 10:05
SEAPORT THERAPEUTICS, INC. <SPTX.O>: H.C. WAINWRIGHT INITIATES COVERAGE WITH BUY RATING AND TARGET PRICE $50
Reuters · 07/15 10:04
Seaport Therapeutics participates in a conference call with JPMorgan
TipRanks · 07/14 18:50
More
About SPTX
Seaport Therapeutics, Inc. is a clinical-stage therapeutics company. The Company is focused on inventing and developing new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. Its product candidate, GlyphAllo (SPT-300 or Glyph Allopregnanolone), is a novel, Glyphed oral prodrug of allopregnanolone, an endogenous molecule that has been clinically validated in third-party trials for the treatment of postpartum depression. GlyphAgo (SPT-320 or Glyph Agomelatine), is a novel, Glyphed oral prodrug of agomelatine, a clinically validated anxiolytic and antidepressant that is approved for the treatment of generalized anxiety disorder. It is also advancing Glyph2BLS (SPT-348 or Glyph 2-bromo-LSD), a novel, Glyphed oral prodrug of the non-hallucinogenic LSD analog 2-bromo-LSD, in preclinical studies for depressive disorders. GlyphAllo is designed to overcome the bioavailability limitations of allopregnanolone and be durable in MDD.

Webull offers Seaport Therapeutics stock information, including NASDAQ: SPTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SPTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SPTX stock methods without spending real money on the virtual paper trading platform.